UK Clears Glaxo’s $700000 ‘Bubble Boy Disease’ Gene Therapy – Bloomberg
Bloomberg |
UK Clears Glaxo's $700000 'Bubble Boy Disease' Gene Therapy
Bloomberg The U.K.'s thrifty health authority has cleared its most expensive medicine ever — a $700,000 GlaxoSmithKline Plc treatment for an illness known as “bubble-boy disease.” But the overall cost to the country's medical system won't be as eye-popping as … |
